On the evening of December 19, Heavy Pharmaceutical Holdings (000950) announced that it received a relevant notification letter issued by Qiu Tian, the company's chief financial officer and secretary of the board of directors, based on its firm confidence in the company's future performance growth and development prospects and a reasonable judgment of the company's current stock price, with its own funds of about 10190,000 yuan, through the Shenzhen Stock Exchange trading system to increase the company's shares by centralized bidding 2050,000 shares, with an average price of 4$97 shares. Previously, Qiu Tian held 1,000 shares of the company.
Qiu Tian said that within 6 months after the completion of the increase and within the statutory period, he will not hold the company's shares, do not conduct insider trading and trading, and do not buy and sell the company during the sensitive periodAt the same time, under the condition of complying with the relevant regulations, it is not excluded that the possibility of continuing to increase the company's shares in a legal and compliant manner under suitable circumstances in the future is not ruled out.
On October 27 this year, Yuan Quan, chairman of Heavy Pharmaceutical Holdings, also increased his holdings in the company by 18560,000 shares, with an average increase of 491 yuan shares, the amount of increase is about 91130,000 yuan. Before the implementation of this increase, Yuan Quan did not hold shares of the company.
New Taizheng (002968) also announced that some directors and senior managers plan to increase their holdings of the company's shares through centralized bidding on the Shenzhen Stock Exchange within 6 months from December 19, with a total increase of not less than 10.7 million yuan, and no ** range is set.
The new Dazheng intends to increase its holdings including the company's director, CEO (president) Liu Wenbo, chief operating officer Gao Wentian, chief marketing officer Tian Weizheng, secretary of the board of directors Weng Jialin and financial director, chief financial officer Yang Tan, the amount of increased holdings is not less than 5.5 million yuan, 1.5 million yuan, 2 million yuan, 900,000 yuan and 800,000 yuan respectively, the above five people themselves are shareholders of the company, the number of shares from 9800,000 shares to 68600,000 shares. The increase is based on confidence in the company's future development prospects and recognition of the company's long-term value, in order to better support the company's sustainable, stable and healthy development.
It is understood that on November 28 this year, New Taizheng also began to implement the repurchase of shares, and a total of 6 shares were repurchased on the same day600,000 shares, accounting for 0029% and the transaction price was 13$68 shares to $1343 yuan shares, the total transaction amount is about 89620,000 yuan (excluding transaction costs). According to the plan, the total amount of funds to be used for repurchase shall not be less than 15 million yuan, not more than 20 million yuan, and the repurchase ** shall not exceed 2043 yuan shares, the repurchased ones are intended to be used for the subsequent implementation of employee stock ownership plans or equity incentives.
Upstream news reporter Liu Yong and Xi student Wang Yanmei.